Alligator Bioscience AB Stock
Stocks
ATORX
SE0024173637
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 0.0101 SEK | -4.72% |
|
-22.31% | -97.00% |
| 10-22 | Alligator Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
| 10-22 | Alligator Bioscience AB, Q3 2026 Earnings Call, Oct 22, 2026 |
| Market Cap | 6.66M 671K 599K 553K 501K 938K 63.67M 954K 2.64M 33.36M 2.52M 2.46M 105M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 6.66M 671K 599K 553K 501K 938K 63.67M 954K 2.64M 33.36M 2.52M 2.46M 105M | EV / Sales 2026 * |
5.55x | EV / Sales 2027 * | 0.13x |
| Free-Float |
38.38% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ATORX | Delayed | |
London S.E.
| 0RK9 | Delayed | |
|
OTC Markets
| ALLGF | Delayed | |
|
Deutsche Boerse AG
| 7AL0 | Delayed | |
|
CBOE
| 0RK9 | Real-time | |
|
CBOE
| ATORXs | Real-time | |
|
Börse Stuttgart
| 7AL0 | Delayed |
Last Transcript: Alligator Bioscience AB
| 1 day | -4.72% | ||
| 1 week | -22.31% | ||
| Current month | -49.50% | ||
| 1 month | -52.36% | ||
| 3 months | -94.79% | ||
| 6 months | -95.88% | ||
| Current year | -97.00% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.02 |
| Current year | 0.01 | | 0.49 |
| 1 year | 0.01 | | 2.38 |
| 3 years | 0.01 | | 1,568 |
| 5 years | 0.01 | | 2,995 |
| 10 years | 0.01 | | 40,100 |
| Manager | Title | Age | Since |
|---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 55 | 2021-05-31 |
Johan Gileus
DFI | Director of Finance/CFO | 61 | 2024-08-11 |
Tom Moore
CTO | Chief Tech/Sci/R&D Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | - | |
| Director/Board Member | 64 | 2021-05-31 | |
Denise Goode
BRD | Director/Board Member | 68 | 2022-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/5/25 | Buy | Chairman | 800,000 | 0.0047% | ||
| 3/5/25 | Buy | Chairman | 77,319 | 0.0005% | ||
| 3/5/25 | Sell | Chairman | 1,658,134 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.72% | -22.31% | -99.63% | -100.00% | 671K | |
| +2.41% | -6.33% | +43.43% | +71.02% | 63.29B | |
| -0.15% | +3.11% | +10.29% | +72.56% | 54.89B | |
| +0.57% | +4.64% | +12.82% | +89.79% | 53.28B | |
| +0.37% | +4.67% | +27.03% | +52.07% | 45.81B | |
| -1.21% | +2.32% | +21.80% | +123.81% | 43.46B | |
| -0.37% | +5.07% | +249.91% | +918.74% | 40.23B | |
| +0.05% | +6.75% | +14.48% | +56.75% | 33.45B | |
| +1.19% | -5.84% | +27.86% | -0.65% | 23.7B | |
| -0.38% | +5.68% | +36.43% | +27.54% | 23.76B | |
| Average | -0.22% | -1.55% | +34.44% | +131.16% | 38.19B | |
| Weighted average by Cap. | +0.38% | +0.55% | +47.78% | +158.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.9M 594K 531K 490K 444K 831K 56.42M 845K 2.34M 29.56M 2.23M 2.18M 93.19M | 49.7M 5.01M 4.47M 4.13M 3.74M 7M 475M 7.12M 19.68M 249M 18.79M 18.39M 785M |
| Net income | -15.2M -1.53M -1.37M -1.26M -1.14M -2.14M -145M -2.18M -6.02M -76.15M -5.75M -5.62M -240M | 28.9M 2.91M 2.6M 2.4M 2.18M 4.07M 276M 4.14M 11.44M 145M 10.93M 10.69M 456M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | SEK 0.0101 | -4.72% | 124,637,325 |
| 26-10-22 | SEK 0.0106 | -1.85% | 63,474,371 |
| 26-10-21 | SEK 0.0108 | -6.90% | 32,693,949 |
| 26-10-20 | SEK 0.0116 | -7.94% | 44,026,390 |
| 26-10-19 | SEK 0.0126 | -4.55% | 6,815,229 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ATORX Stock
Select your edition
All financial news and data tailored to specific country editions
